PPARG

Overview

Peroxisome proliferator-activated receptor gamma (PPARγ), encoded by the PPARG gene (Wikidata: Q20970208), is a ligand-activated nuclear receptor and transcription factor belonging to the nuclear receptor superfamily. It is most highly expressed in adipose tissue but is also present in macrophages, the colon, skeletal muscle, and the central nervous system. PPARγ functions as a master regulator of adipogenesis and lipid metabolism, orchestrating the transcriptional programs that govern fat cell differentiation, fatty acid storage, and glucose homeostasis. Upon activation by endogenous ligands — including polyunsaturated fatty acids and eicosanoids — or pharmacological agonists such as thiazolidinediones, PPARγ forms obligate heterodimers with retinoid X receptors (RXRs) and binds to peroxisome proliferator response elements (PPREs) in target gene promoters to regulate downstream transcription.

Beyond its canonical metabolic roles, PPARγ exerts broad anti-inflammatory effects by antagonizing nuclear factor kappa B (NF-κB) signaling and suppressing pro-inflammatory cytokine production, including interleukin-6. These dual metabolic and immunomodulatory functions have made PPARγ a high-value therapeutic target across a spectrum of conditions ranging from type 2 diabetes and non-alcoholic fatty liver disease to neurological injury and chronic inflammation. Its close paralog, PPARα (encoded by PPARA), governs fatty acid oxidation in complementary fashion, and the interplay between PPARγ and PPARα is a recurring theme in studies of lipid homeostasis and metabolic disease.

Focus of Latest Publications

Recent publications highlight PPARγ as a mechanistic node across neurological, metabolic, hepatic, and inflammatory research contexts.

Neurological injury. A 2026 study in Experimental Neurology (PMID: 41581691) demonstrated that miR-27a-3p directly represses PPARγ in the context of subarachnoid hemorrhage (SAH)-induced white matter injury in rats. Mechanistically, suppression of PPARγ led to downregulation of its downstream target peroxiredoxin 1 (PRDX1) and consequent activation of the JNK pathway, triggering oligodendrocyte apoptosis and white matter damage. Delivery of a miR-27a-3p antagomir via BV2 cell-derived exosomes restored PPARγ activity, attenuated JNK-mediated apoptosis, and alleviated white matter injury — establishing the PPARγ/PRDX1/JNK axis as a tractable therapeutic target in hemorrhagic stroke. This work also intersects with research on APP and JUN, which a network pharmacology study on Alzheimer's disease (PMID: 41922822) identified alongside PPARγ as core mechanistic nodes linking a diverse library of ethnopharmacological compounds to neurodegeneration.

Metabolic disease and gut physiology. In a study examining leptin treatment in UC Davis type-2 diabetes mellitus (UCD-T2DM) rats (American Journal of Physiology, PMID: 41875058), colonic Pparg expression was significantly downregulated alongside Ldha in leptin-treated animals compared to controls, while PHD2 and occludin protein levels increased. Elevated levels of short-chain fatty acids — butyric, isocaproic, and valeric acids — were detected in colonic content by metabolomics, suggesting that leptin-mediated metabolic improvement modulates PPARγ-dependent colonocyte gene programs independently of significant changes to the gut microbiome. This finding connects PPARγ regulation to human gut flora-associated metabolite signaling and the broader axis between intestinal barrier integrity and systemic glucose homeostasis. Separately, a computational and experimental validation study (Food & Function, PMID: 41923660) identified PPARγ as one of several key insulin-resistance targets — alongside GLP1R, INSR, FGFR1, and IGF1R — for the natural compounds xanthohumol and cirsilineol, proposed as multi-target therapeutics for type 2 diabetes discovered using the SELFormer machine learning framework.

Hepatic lipid metabolism. Research on fermented pine pollen (Food Chemistry, PMID: 41762882) showed that treatment with Aspergillus niger-fermented pine pollen (FPP) suppressed hepatic lipogenesis in an alcoholic fatty liver disease (AFLD) model by downregulating PPARγ and SREBP-1c, while simultaneously promoting fatty acid oxidation through upregulation of PPARα and CPT1. This mechanistic balance between PPARγ-driven lipogenesis and PPARα-driven oxidation underscores the importance of coordinating both nuclear receptors in interventions targeting hepatic steatosis. FASN, a lipogenic enzyme transcriptionally regulated downstream of PPARγ, is a relevant effector in this pathway.

Skeletal muscle and fetal development. A study in preterm fetal sheep receiving parenteral lipid emulsion (Intralipid 20®) reported no significant effect on intramuscular adipogenesis-associated genes, including Pparg, Pdgfra, Zfp423, Slc27a1, C/ebpa, and FASN (Experimental Physiology, PMID: 41955312). This null finding is informative, suggesting that exogenous lipid delivery in the preterm fetal context does not activate PPARγ-dependent adipogenic programs in skeletal muscle, with potential implications for nutritional strategies in premature neonates.

Inflammation. A study on chestnut wood extract (PLOS ONE, PMID: 42054386) positioned PPARγ as a central mediator of the extract's dual antioxidant and anti-inflammatory activity, acting in opposition to NF-κB pathway activation. This finding aligns with the established paradigm in which PPARγ agonism suppresses TLR4-mediated inflammatory cascades and cytokine signaling, including interleukin-6 production.

Key Publications

• May Exosomes-mediated delivery of miR-27a-3p antagomir alleviates white matter injury by regulating PPARγ/PRDX1/JNK pathway after subarachnoid hemorrhage in rats. (Experimental neurology, 2026, PMID 41581691): "Mechanistically, miR-27a-3p inhibited PPARγ, resulting in downregulation of PRDX1 and activation of the JNK pathway, which triggered oligodendrocyte apoptosis."
• May Improvement of glucose homeostasis during leptin treatment does not alter the intestinal microbiome in male diabetic UC Davis type-2 diabetes mellitus rats. (American journal of physiology. Gastrointestinal and liver physiology, 2026, PMID 41875058): "Butyric, isocaproic, and valeric acids levels were increased in colonic content, colonic gene expression of Pparg and Ldha was downregulated, whereas PHD2 and Occludin protein levels were upregulated in leptin-treated compared with control."
• May Lipid emulsion modulates myogenic and collagen-related gene expression in skeletal muscle of preterm fetal sheep. (Experimental physiology, 2026, PMID 41955312): "In contrast, Intralipid had no significant effect on the expression of genes associated with intramuscular adipogenesis, including Pparg (peroxisome proliferator-activated receptor γ), Pdgfra (platelet-derived growth factor receptor α), Zfp423 (zinc finger protein 423), Slc27a1 (solute carrier family 27 member 1), C/ebpa (CCAAT/enhancer-binding protein α) and Fasn (fatty acid synthase)."
• May Turning off inflammation naturally via dual antioxidant and anti-inflammatory actions of chestnut wood extract through PPARγ and NF-κB pathways. (PloS one, 2026, PMID 42054386): "Turning off inflammation naturally via dual antioxidant and anti-inflammatory actions of chestnut wood extract through PPARγ and NF-κB pathways."
• May Enhancement in the nutritional profile and hepatoprotective activity of pine pollen via Aspergillus niger fermentation. (Food chemistry, 2026, PMID 41762882): "Mechanistically, FPP suppressed lipogenesis by downregulating PPARγ and SREBP-1c, while promoting fatty acid oxidation through upregulation of PPARα and CPT1."
• Apr SELFormer-guided discovery of xanthohumol and cirsilineol as multi-target natural therapeutics for type 2 diabetes: computational prediction and experimental validation. (Food & function, 2026, PMID 41923660): "...including glucagon-like peptide-1 receptor (GLP1R), kinesin family member-11 (KIF11) for insulin secretion and insulin receptor (INSR), peroxisome proliferator-activated receptor-gamma (PPARG), fibroblast growth factor receptor-1 (FGFR1) and insulin-like growth factor-1 receptor (IGF1R) for insulin resistance."
• Apr Medicinal seahorses (Hippocampus spp.) for Alzheimer's disease within species conservation framework: an integrated review of ethnopharmacology, bioactivity, bibliometrics, and network pharmacology. (Naunyn-Schmiedeberg's archives of pharmacology, 2026, PMID 41922822): "Network-pharmacology analysis links 276 structurally defined compounds to an AD-associated gene module, highlighting a core module centered on APP, JUN and PPARγ as putative mechanistic nodes."